Santhera Pharmaceuticals Holding AG
XBER:S3F
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santhera Pharmaceuticals Holding AG
XBER:S3F
|
CH |
|
S
|
Santhera Pharmaceuticals Holding AG
OTC:SPHDF
|
CH |
|
Enagas SA
LSE:0EBQ
|
ES |
|
Athabasca Oil Corp
F:ATI
|
CA |
|
A
|
Alba Mineral Resources PLC
F:9AB
|
UK |
|
Risma Systems A/S
F:8WX
|
DK |
Wall St Price Targets
S3F Price Targets Summary
Santhera Pharmaceuticals Holding AG
According to Wall Street analysts, the average 1-year price target for S3F is 240.53 EUR with a low forecast of 216.52 EUR and a high forecast of 270.11 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is S3F's stock price target?
Price Target
240.53
EUR
According to Wall Street analysts, the average 1-year price target for S3F is 240.53 EUR with a low forecast of 216.52 EUR and a high forecast of 270.11 EUR.
What is the Revenue forecast for Santhera Pharmaceuticals Holding AG?
Projected CAGR
49%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 49%.
What is the Gross Profit forecast for Santhera Pharmaceuticals Holding AG?
Projected CAGR
-19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 4 years is -19%.
